See also this year's filing and all EDGAR filings for this company.
PDF Report 0001728328_2022_InMed_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001728328')"} |
Graph
Absolute values for 0001728328, InMed Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,378,269 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,061,697 |
| 2 | PropertyPlantAndEquipmentNet | 326,595 |
| 3 | remainder_Assets | 14,655 |
| 4 | LiabilitiesCurrent | 2,215,361 |
| 5 | LiabilitiesNoncurrent | 189,288 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,479,333 |
| 9 | ResearchAndDevelopmentExpense | 5,338,084 |
| 10 | remainder_Expenses | 120,866 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -264,806 |
| 13 | remainder_ComprehensiveNetIncome | 430,443 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,781,216 |
| 1 | Liabilities | 2,404,649 |
| 2 | Expenses | 9,938,283 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,376,567 |
| 5 | NetIncome | -10,203,089 |
| 6 | ComprehensiveNetIncome | -9,987,868 |
| 7 | BaseVar | 11,409,698 |
| 8 | EconomicCapitalRatio | 0.443 |
Edgar->Model Mapping
Feature Distribution
Change over Time
